myNEO has won the 2022 Most Disruptive Innovator award

myNEO has won Deloitte's 2022 Most Disruptive Innovator award. This award, which is part of the Rising Star category of the Deloitte Technology Fast 50 competition, recognizes a promising company that has been active in the antigen discovery technology sector for less than four years for its revolutionary product or concept. The announcement was made at the Technology Fast 50 Awards Ceremony on 27 October 2022.

“We are proud to have won Deloitte's 2022 Most Disruptive Innovator award. It's exciting to be recognized for developing the most revolutionary service in this year's Rising Star competition.”